Not finding it? Sign in to also search OpenAlex live.
-
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]
Paul Andrew Cohen, Aime Powell, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Kishor Bulsara, +22 more
2citations -
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448
Paul Andrew Cohen, Aime Powell, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Kishor Bulsara, +22 more
0citations -
Corrigendum to “De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel”
Ulrike Anneliese Nitz, Oleg Gluz, Mathias Christgen, E.‐M. Grischke, Doris Augustin, Sherko Küemmel, +14 more
1citations
3 results